» Articles » PMID: 1379414

Development, Multiplexing, and Application of ARMS Tests for Common Mutations in the CFTR Gene

Overview
Journal Am J Hum Genet
Publisher Cell Press
Specialty Genetics
Date 1992 Aug 1
PMID 1379414
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

The amplification refractory mutation system (ARMS) is a simple, rapid and reliable method for the detection of any mutation involving single base changes or small deletions. We have applied ARMS methodology to the detection of mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Single ARMS tests have been developed for 11 CFTR mutations found in the northwest of England. ARMS reactions for the most common mutations have been multiplexed to give a test which will detect the presence of the delta F508, G551D, G542X, and 621 + 1G----T mutations in a DNA sample. The multiplex test has been validated by the analysis of over 500 previously genotyped samples and has been found to be completely accurate. The rapid detection of the most common mutations has enabled early molecular confirmation of suspected cystic fibrosis in neonates, rapid typing of cystic fibrosis patients and their relatives, and testing of sperm and egg donors.

Citing Articles

Study of a panel of genetic mutations in fibrocalcific pancreatic diabetes (FCPD): SPINK1 (N34S) mutation unlikely to be relevant.

Budhwar V, Dutta S, Pandit K, Mukhopadhyay P, Bhattacharyya N, Ghosh S Sci Rep. 2024; 14(1):31829.

PMID: 39738564 PMC: 11686347. DOI: 10.1038/s41598-024-83113-z.


Universal probe-based intermediate primer-triggered qPCR (UPIP-qPCR) for SNP genotyping.

Li B, Liu Y, Hao X, Dong J, Chen L, Li H BMC Genomics. 2021; 22(1):850.

PMID: 34819030 PMC: 8611915. DOI: 10.1186/s12864-021-08148-2.


Cystic Fibrosis Newborn Screening in Portugal: PAP Value in Populations with Stringent Rules for Genetic Studies.

Marcao A, Barreto C, Pereira L, Vaz L, Cavaco J, Casimiro A Int J Neonatal Screen. 2020; 4(3):22.

PMID: 33072945 PMC: 7548908. DOI: 10.3390/ijns4030022.


Screening for the Most Common Mutations of Gene among Egyptian Children with Difficult-to-Treat Asthma.

Al-Haggar M, Osman E, Eid A, Barakat T, El-Morsi S J Pediatr Genet. 2020; 9(3):164-170.

PMID: 32714616 PMC: 7375845. DOI: 10.1055/s-0040-1701446.


Association of Serum TGF-β1 Levels with Different Clinical Phenotypes of Cystic Fibrosis Exacerbation.

Sagwal S, Chauhan A, Kaur J, Prasad R, Singh M, Singh M Lung. 2020; 198(2):377-383.

PMID: 31919585 DOI: 10.1007/s00408-020-00320-x.


References
1.
Wyman A, White R . A highly polymorphic locus in human DNA. Proc Natl Acad Sci U S A. 1980; 77(11):6754-8. PMC: 350367. DOI: 10.1073/pnas.77.11.6754. View

2.
Saiki R, Bugawan T, Horn G, Mullis K, Erlich H . Analysis of enzymatically amplified beta-globin and HLA-DQ alpha DNA with allele-specific oligonucleotide probes. Nature. 1986; 324(6093):163-6. DOI: 10.1038/324163a0. View

3.
Southern E . Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol. 1975; 98(3):503-17. DOI: 10.1016/s0022-2836(75)80083-0. View

4.
Cutting G, Kasch L, Rosenstein B, Zielenski J, Tsui L, Antonarakis S . A cluster of cystic fibrosis mutations in the first nucleotide-binding fold of the cystic fibrosis conductance regulator protein. Nature. 1990; 346(6282):366-9. DOI: 10.1038/346366a0. View

5.
Zielenski J, Bozon D, Kerem B, Markiewicz D, Durie P, Rommens J . Identification of mutations in exons 1 through 8 of the cystic fibrosis transmembrane conductance regulator (CFTR) gene. Genomics. 1991; 10(1):229-35. DOI: 10.1016/0888-7543(91)90504-8. View